Companies / Industrials
TXT
Textron
Aerospace & Defense
Aerospace & DefenseAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health62
Growth46
Profitability37
Cash generation54
Balance sheet70
Dilution control100
Key ratios and five-year financials
Latest quarter revenue YoY (2026-10-03)4.1%Revenue growth (FY)8.0%Revenue CAGR (3y)4.8%Gross margin—Operating margin—Net margin6.2%Free cash flow margin6.3%R&D / revenue3.5%Stock comp / revenue0.5%Net debt / operating cash flow—Current ratio—Diluted share count change-5.3%
| Fiscal year ending | FY 2022-01 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2026-01 |
|---|---|---|---|---|---|
| Revenue | $12.4B | $12.9B | $13.7B | $13.7B | $14.8B |
| Net income | $746M | $861M | $921M | $824M | $921M |
| Operating cash flow | $1.6B | $1.5B | $1.3B | $1.0B | $1.3B |
| Capital expenditure | $375M | $354M | $402M | $364M | $383M |
| Free cash flow | $1.2B | $1.1B | $864M | $650M | $929M |
| R&D | $619M | $601M | $570M | $491M | $521M |
| Stock-based comp | $138M | $66M | $94M | $66M | $81M |
| Buybacks | $921M | $867M | $1.2B | $1.1B | $822M |
| Dividends | $18M | $17M | $16M | $12M | $18M |
| Cash | $2.1B | $2.0B | $2.2B | $1.4B | $2.0B |
| Equity | $6.8B | $7.1B | $7.0B | $7.2B | $7.9B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.